AtriCure (ATRC) Tops Q1 EPS by 6c ; Offers Guidance

AtriCure (NASDAQ: ATRC) reported Q1 EPS of $0.00, $0.06 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $141.2 million versus the consensus estimate of $139.54 million.

GUIDANCE:

AtriCure sees FY2026 EPS of $0.00-$0.04, versus the consensus of $0.14. AtriCure sees FY2026 revenue of $600-610 million, versus the consensus of $604.1 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• Lazard Global Total Return fund declares $0.1534 monthly distribution
• Wolfe Research sees CNH stock flat 2027 outlook on commodity prices